Kirill Tashilov

Kirill Tashilov is an accomplished investor and board member currently serving as a General Partner at Talis Capital, a venture capital firm based in London. He has a strong background in supporting early-stage companies, particularly in the fields of biotechnology and technology. Tashilov is notably involved with Monomer Bio, a startup focused on laboratory automation and data analytics for drug discovery, where he plays a key role on the board and was instrumental in securing a $5.6 million seed funding round for the company.34

Background and Education

Born in Russia and raised in the Czech Republic, Tashilov pursued his education at The Hong Kong University of Science and Technology, where he earned a Bachelor's degree in 2018. He is multilingual, fluent in English, Czech, and Russian, which complements his international experience in finance and investment.12

Professional Experience

Tashilov has been with Talis Capital since 2018, starting as an Analyst and progressing through various roles to his current position as General Partner. His work primarily involves identifying and nurturing startups that have the potential to redefine their respective industries. He has led investments in several companies, including Seqera Labs, SoWork, and IMMO, among others.12

In addition to his role at Talis Capital, Tashilov has been actively involved with Monomer Bio, where he emphasizes the importance of their platform in overcoming challenges in the cell and gene therapy sectors. His insights reflect a commitment to advancing scientific research through innovative technology solutions.345

Contributions and Vision

Tashilov's investment philosophy focuses on leveraging automation and artificial intelligence to enhance laboratory efficiency, thereby accelerating the pace of scientific discovery. His leadership in funding rounds and board activities positions him as a significant figure in the intersection of technology and life sciences.45